Diagnostic impact of dysmorphic red blood cells on evaluating microscopic hematuria: the urologist's perspective

Kyo Chul Koo1, Kwang Suk Lee1, Ah Ran Choi2

  • 1Department of Urology, Yonsei University College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul, 135-720, Republic of Korea.

Insights

Dysmorphic red blood cells (dRBCs) indicate glomerular disease, but urological evaluation is crucial for microscopic hematuria (MH). Omitting urological assessment risks missing significant conditions, including malignancies.

Area of Science:

  • Nephrology
  • Urology
  • Internal Medicine

Background:

  • Dysmorphic red blood cells (dRBCs) are key indicators of glomerular disease in microscopic hematuria (MH) evaluation.
  • Current guidelines vary on whether to pursue urological evaluation alongside nephrological assessment for MH.

Purpose of the Study:

  • To assess the feasibility and safety of omitting urological evaluation in patients presenting with microscopic hematuria.
  • To determine the diagnostic value of dRBCs in differentiating glomerular from urological causes of MH.

Main Methods:

  • Retrospective analysis of 411 patients with MH (≥3 RBCs/high-power field) between 2012-2014.
  • All patients underwent comprehensive urological and nephrological evaluations, including imaging and biopsy when indicated.

Main Results:

  • A higher median %dRBC was observed in glomerular disease (40.4%) compared to urological disease (21.1%).
  • Among patients with ≥40% dRBCs, 34% had urological conditions, including malignancies and those requiring immediate treatment.
  • Proteinuria was a stronger predictor of glomerular disease than %dRBC ≥40%.

Conclusions:

  • While %dRBC ≥40% has modest value for glomerular disease, proteinuria is more indicative of a glomerular origin.
  • Urological evaluation is essential in patients with MH due to the significant prevalence of treatable urological conditions.
Abstract